Publicaciones etiquetadas ‘Recursos’

Recursos

Background and design of the symptom burden in end-stage liver disease patient-caregiver dyad study.

Related Articles Background and design of the symptom burden in end-stage liver disease patient-caregiver dyad study. Res Nurs Health. 2017 Oct;40(5):398-413 Authors: Hansen L, Lyons KS, Dieckmann NF, Chang MF, Hiatt S, Solanki E, Lee CS Abstract Over half a million Americans are affected by cirrhosis, the cause of end-stage liver disease (ESLD). Little is known about how symptom burden changes over time in adults with ESLD and their informal caregivers, which limits our ability to develop palliative care interventions that can optimize symptom management and quality of life in different patient-caregiver dyads. The purpose of this article is to…
Origen: Background and design of the symptom burden in end-stage liver disease patient-caregiver dyad study. – PubMed

Leer más

Recursos

Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia.

Related Articles Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia. Leuk Lymphoma. 2018 05;59(5):1095-1104 Authors: Sanchez-Garcia J, Falantes J, Medina Perez A, Hernandez-Mohedo F, Hermosin L, Torres-Sabariego A, Bailen A, Hernandez-Sanchez JM, Solé Rodriguez M, Casaño FJ, Calderon C, Labrador M, Vahí M, Serrano J, Lumbreras E, Hernández-Rivas JM, Grupo Andaluz SMD Abstract In this prospective trial, the efficacy of azacitidine in lower-risk myelodysplastic syndromes (LR-SMD) lacking del(5q) was compared to best supportive care (BSC) at 1:1. The primary endpoint was the achievement of erythroid hematologic…
Origen: Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia. – PubMed

Leer más

Recursos

Successful use of palliative inotrope therapy in end-stage cardiac ATTR amyloidosis.

Related Articles Successful use of palliative inotrope therapy in end-stage cardiac ATTR amyloidosis. Amyloid. 2017 12;24(4):217-218 Authors: Panhwar MS, Al-Kindi S, Oliveira GH, Ginwalla M PMID: 28868918 [PubMed – indexed for MEDLINE]
Origen: Successful use of palliative inotrope therapy in end-stage cardiac ATTR amyloidosis. – PubMed

Leer más

Recursos

Parental hopes, interventions, and survival of neonates with trisomy 13 and trisomy 18.

Related Articles Parental hopes, interventions, and survival of neonates with trisomy 13 and trisomy 18. Am J Med Genet C Semin Med Genet. 2016 Sep;172(3):279-87 Authors: Janvier A, Farlow B, Barrington KJ Abstract Trisomy 13 and 18 are life-limiting conditions for which a palliative approach is frequently recommended. The objective of this study was to examine parental goals/decisions, the length of life of their child and factors associated with survival. Parents of children who lived with trisomy 13 or 18 that were part of English-speaking social networks were invited to participate in a questionnaire study. Participants answered questions about their…
Origen: Parental hopes, interventions, and survival of neonates with trisomy 13 and trisomy 18. – PubMed

Leer más

Recursos

Surgical repair of Tetralogy of Fallot following primary palliation: Right ventricular outflow track stenting versus modified Blalock-Taussig shunt.

Related Articles Surgical repair of Tetralogy of Fallot following primary palliation: Right ventricular outflow track stenting versus modified Blalock-Taussig shunt. Indian Heart J. 2018 Dec;70 Suppl 3:S394-S398 Authors: Bigdelian H, Ghaderian M, Sedighi M Abstract BACKGROUND: Tetralogy of Fallot (TOF) is a cyanotic disease requiring early intervention. We assessed the effect of right ventricular outflow tract (RVOT) stenting versus modified Blalock-Taussig shunt (mBTS) on outcomes of surgical repair of TOF. METHODS: Fifteen palliated TOF infants underwent complete repair surgery. RVOT stenting was performed in seven infants and mBTS was done in eight infants. Data on sequential patients who underwent surgery…
Origen: Surgical repair of Tetralogy of Fallot following primary palliation: Right ventricular outflow track stenting versus modified Blalock-Taussig shunt. – PubMed

Leer más